The epigenetic modifications of C/EBPα [28] and AML1 [13, 29] at AML and MDS, which participate in AML and MDS leukemogenesis, and the intact differentiation ability of MDS [30] are also supported. The gene discussed is RUNX1; the disease is myelodysplastic syndrome.